Serigen Mediproducts Pvt Ltd., Plot no. 9, Electronic Co-op Estate, Satara Road, Parvati Paytha, Pune 411009, India.
Intox Private Limited, Pune, 375, Urawade, Tal. Mulshi, Pune 412115, India.
ACS Biomater Sci Eng. 2022 Mar 14;8(3):1226-1238. doi: 10.1021/acsbiomaterials.1c01103. Epub 2022 Feb 15.
Silk fibroin (SF) is a natural biocompatible protein polymer extracted from cocoons of silkworm . SF can be processed into a variety of different forms and shapes that can be used as scaffolds to support bone regeneration. Three-dimensional (3D) SF scaffolds have shown promise in bone-void-filling applications. In studies, it has been demonstrated that a microparticle-based SF (M-RSF) scaffold promotes the differentiation of stem cells into an osteoblastic lineage. The expression of differentiation markers was also significantly higher for M-RSF scaffolds as compared to other SF scaffolds and commercial ceramic scaffolds. In this work, we have evaluated the and biocompatibility of M-RSF scaffolds as per the ISO 10993 guidelines in a Good Laboratory Practice (GLP)-certified facility. The cytotoxicity, immunogenicity, genotoxicity, systemic toxicity, and implantation studies confirmed that the M-RSF scaffold is biocompatible. Further, the performance of the M-RSF scaffold to support bone formation was evaluated in bone implantation studies in a rabbit model. Calcium sulfate (CaSO) scaffolds were chosen as reference material for this study as they are one of the preferred materials for bone-void-filling applications. M-RSF scaffold implantation sites showed a higher number of osteoblast and osteoclast cells as compared to CaSO implantation sites indicating active bone remodeling. The number density of osteocytes was double for M-RSF scaffold implantation sites, and these M-RSF scaffold implantation sites were characterized by enhanced collagen deposition, pointing toward a finer quality of the new bone formed. Moreover, the M-RSF scaffold implantation sites had a negligible incidence of secondary fractures as compared to the CaSO implantation sites (∼50% sites with secondary fracture), implying a reduction in postsurgical complications. Thus, the study demonstrates that the M-RSF scaffold is nontoxic for bone-void-filling applications and facilitates superior healing of fracture defects as compared to commercial calcium-based bone void fillers.
丝素蛋白(SF)是一种从蚕茧中提取的天然生物相容性蛋白质聚合物。SF 可以加工成各种不同的形式和形状,可用作支持骨再生的支架。三维(3D)SF 支架在骨腔填充应用中显示出良好的效果。在研究中,已证明基于微粒的 SF(M-RSF)支架可促进干细胞向成骨细胞谱系分化。与其他 SF 支架和商业陶瓷支架相比,M-RSF 支架的分化标志物表达也明显更高。在这项工作中,我们根据 ISO 10993 指南,在经过良好实验室规范(GLP)认证的设施中评估了 M-RSF 支架的和生物相容性。细胞毒性、免疫原性、遗传毒性、全身毒性和植入研究证实,M-RSF 支架具有生物相容性。此外,还在兔模型中进行了骨植入研究来评估 M-RSF 支架支持骨形成的性能。硫酸钙(CaSO)支架被选为该研究的参考材料,因为它们是骨腔填充应用中首选的材料之一。与 CaSO 植入部位相比,M-RSF 支架植入部位的成骨细胞和破骨细胞数量更多,表明有活跃的骨重塑。M-RSF 支架植入部位的骨细胞数量密度是 CaSO 植入部位的两倍,并且这些 M-RSF 支架植入部位的胶原沉积增强,表明形成的新骨质量更高。此外,与 CaSO 植入部位相比,M-RSF 支架植入部位的继发性骨折发生率较低(约 50%的部位发生继发性骨折),这意味着手术后并发症减少。因此,该研究表明,M-RSF 支架对于骨腔填充应用是无毒的,并且与商业钙基骨填充剂相比,它可以促进骨折缺陷的更好愈合。